These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27456016)

  • 1. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.
    Yamashita S; Vauthey JN; Kaseb AO; Aloia TA; Conrad C; Hassan MM; Passot G; Raghav KP; Shama MA; Chun YS
    J Gastrointest Surg; 2016 Oct; 20(10):1725-31. PubMed ID: 27456016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
    Park S; Choi S; Cho YA; Sinn DH; Kim JM; Park CK; Ha SY
    Cancer Res Treat; 2020 Oct; 52(4):1145-1152. PubMed ID: 32599989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.
    Goh BK; Teo JY; Chan CY; Lee SY; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 Jan; 113(1):89-93. PubMed ID: 26611492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver resection for hepatocellular and fibrolamellar carcinoma in a South African tertiary referral centre - an observational cohort analysis.
    Ziaei Y; Krige JEJ; Jonas EG; Kotze UK; Bernon MM; Kloppers C; Sobnach S
    S Afr J Surg; 2024 May; 62(2):13-17. PubMed ID: 38838113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
    Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma.
    Chun YH; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Kim BK; Choi GH; Kim KS; Choi JS; Ahn SH
    Eur J Cancer; 2011 Nov; 47(17):2568-75. PubMed ID: 21835608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.
    Chan AC; Fan ST; Poon RT; Cheung TT; Chok KS; Chan SC; Lo CM
    HPB (Oxford); 2013 Jun; 15(6):439-48. PubMed ID: 23659567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matching.
    Qiu S; Chen R; Hu J; Han T
    Scand J Gastroenterol; 2023; 58(11):1351-1358. PubMed ID: 37353942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
    Bhaijee F; Locketz ML; Krige JE
    S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
    Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
    J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis.
    Xie QS; Chen ZX; Zhao YJ; Gu H; Geng XP; Liu FB
    Asian J Surg; 2021 Jan; 44(1):36-45. PubMed ID: 32988708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of nodules, Child-Pugh status, margin positivity, and microvascular invasion, but not tumor size, are prognostic factors of survival after liver resection for multifocal hepatocellular carcinoma.
    Goh BK; Chow PK; Teo JY; Wong JS; Chan CY; Cheow PC; Chung AY; Ooi LL
    J Gastrointest Surg; 2014 Aug; 18(8):1477-85. PubMed ID: 24855028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
    Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
    Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?
    Bauschke A; Altendorf-Hofmann A; Malessa C; Schüle S; Zanow J; Settmacher U
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2593-2601. PubMed ID: 27630023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.
    Lei HJ; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
    J Am Coll Surg; 2006 Oct; 203(4):426-35. PubMed ID: 17000385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey.
    Hasegawa K; Makuuchi M; Kokudo N; Izumi N; Ichida T; Kudo M; Ku Y; Sakamoto M; Nakashima O; Matsui O; Matsuyama Y;
    Ann Surg; 2014 Jan; 259(1):166-70. PubMed ID: 23532111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
    Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.